• <object id="wi4ek"></object>
    <input id="wi4ek"><acronym id="wi4ek"></acronym></input>
  • <menu id="wi4ek"><u id="wi4ek"></u></menu>
  • <menu id="wi4ek"></menu>
    <menu id="wi4ek"></menu>
    <menu id="wi4ek"><tt id="wi4ek"></tt></menu>
  • <menu id="wi4ek"></menu>
    <input id="wi4ek"></input>
  • <input id="wi4ek"></input>
  • <menu id="wi4ek"></menu>
  • <object id="wi4ek"><acronym id="wi4ek"></acronym></object>
    <menu id="wi4ek"></menu>
  • <input id="wi4ek"><u id="wi4ek"></u></input>
  • Welcome to the official website of Jiangsu WNC Pharmaceutical Co., Ltd.!

    Your location>>Home>>Research

    With the supports of famous universities and institutes such as Nankai University, Shanghai OSD Pharmaceutical Research Institute, Shanghai Pharmaceutical Industry Research Institute, we have developed a series of new intermediate successfully, including aliskiren intermediate, atorvastatin intermediate, ezetimibe intermediate. They have been highly appraised by our customers since they were put into markets.


    The company formed a R&D team in 2006, and our R&D center and production base were respectively used in 2007 and 2008. Based on the most excellent manufacturing technique system, exquisite technology and advanced mechanical equipment, we strive to develop and produce more raw material intermediates of innovative medicines for the treatment of hypertension, hyperlipidemia and other diseases.